509 related articles for article (PubMed ID: 27060526)
1. An evaluation of 30 clinical drugs against the comprehensive in vitro proarrhythmia assay (CiPA) proposed ion channel panel.
Crumb WJ; Vicente J; Johannesen L; Strauss DG
J Pharmacol Toxicol Methods; 2016; 81():251-62. PubMed ID: 27060526
[TBL] [Abstract][Full Text] [Related]
2. Improving the In Silico Assessment of Proarrhythmia Risk by Combining hERG (Human Ether-à-go-go-Related Gene) Channel-Drug Binding Kinetics and Multichannel Pharmacology.
Li Z; Dutta S; Sheng J; Tran PN; Wu W; Chang K; Mdluli T; Strauss DG; Colatsky T
Circ Arrhythm Electrophysiol; 2017 Feb; 10(2):e004628. PubMed ID: 28202629
[TBL] [Abstract][Full Text] [Related]
3. Simulation of multiple ion channel block provides improved early prediction of compounds' clinical torsadogenic risk.
Mirams GR; Cui Y; Sher A; Fink M; Cooper J; Heath BM; McMahon NC; Gavaghan DJ; Noble D
Cardiovasc Res; 2011 Jul; 91(1):53-61. PubMed ID: 21300721
[TBL] [Abstract][Full Text] [Related]
4. Comparative pharmacology of guinea pig cardiac myocyte and cloned hERG (I(Kr)) channel.
Davie C; Pierre-Valentin J; Pollard C; Standen N; Mitcheson J; Alexander P; Thong B
J Cardiovasc Electrophysiol; 2004 Nov; 15(11):1302-9. PubMed ID: 15574182
[TBL] [Abstract][Full Text] [Related]
5. Cardiac voltage-gated ion channels in safety pharmacology: Review of the landscape leading to the CiPA initiative.
Huang H; Pugsley MK; Fermini B; Curtis MJ; Koerner J; Accardi M; Authier S
J Pharmacol Toxicol Methods; 2017 Sep; 87():11-23. PubMed ID: 28408211
[TBL] [Abstract][Full Text] [Related]
6. QT interval prolongation and cardiac risk assessment for novel drugs.
Picard S; Lacroix P
Curr Opin Investig Drugs; 2003 Mar; 4(3):303-8. PubMed ID: 12735231
[TBL] [Abstract][Full Text] [Related]
7. Electrocardiographic biomarkers to confirm drug's electrophysiological effects used for proarrhythmic risk prediction under CiPA.
Vicente J; Hosseini M; Johannesen L; Strauss DG
J Electrocardiol; 2017; 50(6):808-813. PubMed ID: 28928044
[TBL] [Abstract][Full Text] [Related]
8. Cannabidiol inhibits multiple cardiac ion channels and shortens ventricular action potential duration in vitro.
Le Marois M; Ballet V; Sanson C; Maizières MA; Carriot T; Chantoiseau C; Partiseti M; Bohme GA
Eur J Pharmacol; 2020 Nov; 886():173542. PubMed ID: 32910945
[TBL] [Abstract][Full Text] [Related]
9. Human embryonic stem cell derived cardiac myocytes detect hERG-mediated repolarization effects, but not Nav1.5 induced depolarization delay.
Qu Y; Gao B; Fang M; Vargas HM
J Pharmacol Toxicol Methods; 2013; 68(1):74-81. PubMed ID: 23518063
[TBL] [Abstract][Full Text] [Related]
10. The Comprehensive in Vitro Proarrhythmia Assay (CiPA) initiative - Update on progress.
Colatsky T; Fermini B; Gintant G; Pierson JB; Sager P; Sekino Y; Strauss DG; Stockbridge N
J Pharmacol Toxicol Methods; 2016; 81():15-20. PubMed ID: 27282641
[TBL] [Abstract][Full Text] [Related]
11. Proarrhythmic mechanisms of the common anti-diarrheal medication loperamide: revelations from the opioid abuse epidemic.
Kang J; Compton DR; Vaz RJ; Rampe D
Naunyn Schmiedebergs Arch Pharmacol; 2016 Oct; 389(10):1133-7. PubMed ID: 27530870
[TBL] [Abstract][Full Text] [Related]
12. Update on the ECG component of the CiPA initiative.
Vicente J
J Electrocardiol; 2018; 51(6S):S98-S102. PubMed ID: 30121123
[TBL] [Abstract][Full Text] [Related]
13. The atypic antipsychotic clozapine inhibits multiple cardiac ion channels.
Le Marois M; Sanson C; Maizières MA; Partiseti M; Bohme GA
Naunyn Schmiedebergs Arch Pharmacol; 2023 Jan; 396(1):161-166. PubMed ID: 36308551
[TBL] [Abstract][Full Text] [Related]
14. The grapefruit polyphenol naringenin inhibits multiple cardiac ion channels.
Sanson C; Boukaiba R; Houtmann S; Maizières MA; Fouconnier S; Partiseti M; Bohme GA
Naunyn Schmiedebergs Arch Pharmacol; 2022 Jun; 395(6):735-740. PubMed ID: 35412073
[TBL] [Abstract][Full Text] [Related]
15. A temperature-dependent in silico model of the human ether-à-go-go-related (hERG) gene channel.
Li Z; Dutta S; Sheng J; Tran PN; Wu W; Colatsky T
J Pharmacol Toxicol Methods; 2016; 81():233-9. PubMed ID: 27178106
[TBL] [Abstract][Full Text] [Related]
16. Voltage gated ion channels blockade is the underlying mechanism of BIMU8 induced cardiotoxicity.
Iqbal SM; Lemmens-Gruber R
Toxicol Lett; 2017 Aug; 277():64-68. PubMed ID: 28552773
[TBL] [Abstract][Full Text] [Related]
17. Evolving regulatory paradigm for proarrhythmic risk assessment for new drugs.
Vicente J; Stockbridge N; Strauss DG
J Electrocardiol; 2016; 49(6):837-842. PubMed ID: 27524478
[TBL] [Abstract][Full Text] [Related]
18. Recording of multiple ion current components and action potentials in human induced pluripotent stem cell-derived cardiomyocytes via automated patch-clamp.
Mann SA; Heide J; Knott T; Airini R; Epureanu FB; Deftu AF; Deftu AT; Radu BM; Amuzescu B
J Pharmacol Toxicol Methods; 2019; 100():106599. PubMed ID: 31228558
[TBL] [Abstract][Full Text] [Related]
19. Azithromycin Causes a Novel Proarrhythmic Syndrome.
Yang Z; Prinsen JK; Bersell KR; Shen W; Yermalitskaya L; Sidorova T; Luis PB; Hall L; Zhang W; Du L; Milne G; Tucker P; George AL; Campbell CM; Pickett RA; Shaffer CM; Chopra N; Yang T; Knollmann BC; Roden DM; Murray KT
Circ Arrhythm Electrophysiol; 2017 Apr; 10(4):. PubMed ID: 28408648
[TBL] [Abstract][Full Text] [Related]
20. Characterization of loperamide-mediated block of hERG channels at physiological temperature and its proarrhythmia propensity.
Sheng J; Tran PN; Li Z; Dutta S; Chang K; Colatsky T; Wu WW
J Pharmacol Toxicol Methods; 2017; 88(Pt 2):109-122. PubMed ID: 28830713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
